Related Experiment Videos
[Thymectomy in myasthenia gravis: long-term evolution and predictive factors]
J Pérez-Nellar1, A Negrín, J A Llorens
1Servicio de Neurología, Hospital Clínico Quirúrgico Hermanos Ameijeiras, La Habana, Cuba. jpnellar@yahoo.com
Revista De Neurologia
|June 28, 2000
Summary
Thymectomy offers good long-term outcomes for myasthenia gravis patients, with remission rates increasing over time. This surgical treatment
Area of Science:
- Neurology
- Surgical Oncology
Context:
- Myasthenia gravis is a chronic autoimmune neuromuscular disease.
- Thymectomy is a standard treatment for myasthenia gravis.
Purpose:
- To evaluate the long-term effectiveness of thymectomy in 217 myasthenia gravis patients.
- To analyze remission rates, mortality, and influencing factors post-thymectomy.
Summary:
- Thymectomy demonstrated good long-term results in 217 myasthenia gravis patients.
- Remission rates improved over time, reaching 47% after ten years.
- Thymomas were associated with poorer outcomes and higher mortality.
Impact:
- Provides evidence supporting thymectomy as an effective treatment for myasthenia gravis.
- Offers insights into factors influencing long-term remission and survival.
- Contributes to the international understanding of thymectomy outcomes in myasthenia gravis management.